Companies Cryptocurrencies
Arcutis Biotherapeutics Inc
Arcutis Biotherapeutics Inc
Exchange: NasdaqGS
IPO Date: 31/01/2020
CEO: Mr. Todd Franklin Watanabe
Biotechnology Healthcare 🔗
  • ARQT
  • 25.13
  • 1512511872
    market cap
  • 0.29999924
If you bought

shares of Arcutis Biotherapeutics Inc (ARQT) on
You would have made
Old Price $12 Current Price $12

Arcutis Biotherapeutics Inc. is a late-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases. Its portfolio is comprised of topical treatments with potential to address immune-mediated dermatological diseases and conditions, or immuno-dermatology. Its strategy is to identify and develop treatments against validated biological targets in dermatology that deliver a differentiated clinical profile that addresses major shortcomings of existing therapies in targeted indications. Its products pipelines include ARQ-151, ARQ-154, ARQ-252 and ARQ-255.

Address: 2945 Townsgate Road Suite 110 Westlake Village CALIFORNIA 91361

Stay updated.